Galectin Therapeutics Q3 EPS $(0.14), Same YoY

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.14) per share. This is unchanged from the same period last year.

Galectin Therapeutics (NASDAQ:GALT) reported quarterly losses of $(0.14) per share. This is unchanged from the same period last year.

Total
0
Shares
Related Posts
Read More

Earnings Outlook For Lakeland Bancorp

Lakeland Bancorp (NASDAQ:LBAI) is set to give its latest quarterly earnings report on Thursday, 2022-07-28. Here's what investors need to know before the announcement. Analysts estimate that Lakeland Bancorp will report an earnings per share (EPS) of $0.43.

LBAI